<DOC>
	<DOCNO>NCT00249509</DOCNO>
	<brief_summary>Recent research identify follow withdrawal symptom associate abruptly stop marijuana use : anxiety , irritability , bodily ache pain , difficulty sleep . These symptom resemble depression nicotine withdrawal , suggest similar treatment drug may useful . This study evaluate effectiveness two antidepressant drug , bupropion nefazodone , reduce withdrawal symptom marijuana dependent individual .</brief_summary>
	<brief_title>Effectiveness Nefazodone Bupropion Treating Marijuana Dependent Individuals</brief_title>
	<detailed_description>There control study focus treatment marijuana dependence . The symptom associate marijuana withdrawal , include anxiety , irritability , bodily ache pain , difficulty sleeping , resemble cause depression nicotine withdrawal . Therefore , antidepressant nicotine withdrawal medication may effective treat marijuana dependence . Nefazodone bupropion two medication currently use treat depression . The purpose study determine effectiveness nefazodone bupropion alleviate marijuana withdrawal symptom . In addition , study evaluate whether medication successfully treat marijuana dependent individual term treatment adherence drug abstinence . Participants double-blind trial randomly assign receive nefazodone , bupropion , placebo . Daily dose medication provide participant date pill box ; pill box return study nurse study visit . Medication take three daily dos ; one dose nonmedicated pill . Nefazodone initially give dose 150 mg per day , participant take bedtime . Every 5 day , daily dose increase 150 mg , maximal dose 600 mg nefazodone per day . Bupropion give initial dose 150 mg , participant take morning . After 3 day , daily dose increase total dose 300 mg bupropion per day . Study visit occur daily , time participant complete drug use withdrawal symptom report . In addition , participant partake weekly therapy visit , consist four session motivational enhancement therapy follow session relapse prevention therapy . Bi-weekly psychiatry visit include evaluation substance use behavior overall clinical symptom , last 15-30 minute .</detailed_description>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<mesh_term>Nefazodone</mesh_term>
	<criteria>Meets DSMIV criterion current marijuana dependence Uses least 5 marijuana joint per week Currently seek treatment marijuana dependence Used marijuana maladaptive pattern 6 month prior study entry History seizure unexplained loss consciousness Significant unstable psychiatric condition ( e.g. , schizophrenia , bipolar disorder ) Chronic organic mental disorder Dependent substance abuse marijuana Currently significant suicidal risk Unstable physical disorder may represent severe untreated condition , hypertension ( blood pressure great 150/90 ) , elevate transaminase level , unstable diabetes Current suspect coronary vascular disease Has take monoamine oxidase inhibitor 2 week prior study entry Currently take terfenedine , cisapride , astemizole , pimozide History allergic reaction bupropion nefazodone If female , pregnant , breastfeeding , unwilling use adequate method contraception duration study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>marijuana dependence</keyword>
</DOC>